v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 11,772,163 $ 20,729,983
Accounts receivable 133,500 242,617
Prepaid expenses 1,094,287 521,370
Other current assets 470,103 360,125
Total Current Assets 13,470,053 21,854,095
Property and equipment, net 5,180,551 5,523,013
Operating lease right-of-use assets 569,163 549,504
Intangible assets, net 215,133 23,886
Total Assets 19,434,900 27,950,498
Current Liabilities    
Accounts payable 3,527,673 3,211,287
Accrued liabilities 3,305,316 3,928,761
Deferred revenue 23,000,000 23,000,000
Management and directors' fees payable 60,246 59,625
Current portion of long-term debt 1,149,944 1,207,007
Current portion of finance lease liabilities 47,875 48,570
Current portion of operating lease liabilities 201,047 199,323
Current portion of grant repayable 54,700 55,855
Warrant liability 145,571 126,649
Total Current Liabilities 31,492,372 31,837,077
Long-term debt, net of current portion 3,372,568 3,624,860
Finance lease liabilities, net of current portion 379,667 400,022
Operating lease liabilities, net of current portion 396,376 378,054
Grant repayable, net of current portion 413,968 422,707
Total Long-Term Liabilities 4,562,579 4,825,643
Total Liabilities 36,054,951 36,662,720
Stockholders' Deficit    
Common Stock Authorized: 100,000,000 shares of common stock, at $0.001 par value per share Issued and outstanding: 82,108,972 shares and 81,898,321 shares, respectively 82,109 81,898
Additional paid-in capital 194,997,353 194,448,414
Accumulated other comprehensive income 258,966 243,940
Accumulated deficit (210,943,895) (202,576,507)
Total VolitionRx Limited Stockholders' Deficit (15,605,467) (7,802,255)
Non-controlling interest (1,014,584) (909,967)
Total Stockholders' Deficit (16,620,051) (8,712,222)
Total Liabilities and Stockholders' Deficit $ 19,434,900 $ 27,950,498

Source

10-Q PDF
XBRL